Measure of the Long Term Influence of SPIRIVA® in Acute Respiratory Disorders
Status:
Completed
Trial end date:
2003-10-01
Target enrollment:
Participant gender:
Summary
The objectives of this study were to evaluate the effect of a one-year treatment with inhaled
tiotropium bromide 18 mcg once daily on lung function, incidence and severity of
exacerbations in patients with chronic obstructive pulmonary disease (COPD).
The secondary purpose was to explore possible relationships between lung function changes and
occurrence of COPD exacerbations and to try to characterize these exacerbations.